Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
CNMD

CNMD - CONMED Corp Stock Price, Fair Value and News

71.12USD-1.72 (-2.36%)Market Closed

Market Summary

CNMD
USD71.12-1.72
Market Closed
-2.36%

CNMD Alerts

  • 3 major insider buys recently.
  • Big jump in Earnings (Y/Y)

CNMD Stock Price

View Fullscreen

CNMD RSI Chart

CNMD Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

26.6

Price/Sales (Trailing)

1.74

EV/EBITDA

19.78

Price/Free Cashflow

15.48

CNMD Price/Sales (Trailing)

CNMD Profitability

EBT Margin

8.23%

Return on Equity

9.64%

Return on Assets

3.57%

Free Cashflow Yield

6.46%

CNMD Fundamentals

CNMD Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

5.69%

Rev. Growth (Qtr)

-4.52%

CNMD Earnings

Earnings (TTM)

82.3M

Earnings Growth (Yr)

983.51%

Earnings Growth (Qtr)

-40.4%

Breaking Down CNMD Revenue

Last 7 days

-6.9%

Last 30 days

-4.6%

Last 90 days

-8.2%

Trailing 12 Months

-47.8%

How does CNMD drawdown profile look like?

CNMD Financial Health

Current Ratio

2.18

Debt/Equity

1.16

Debt/Cashflow

0.16

CNMD Investor Care

Dividend Yield

1.12%

Dividend/Share (TTM)

0.8

Shares Dilution (1Y)

0.74%

Diluted EPS (TTM)

2.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.3B000
20231.1B1.1B1.2B1.2B
20221.0B1.0B1.1B1.0B
2021881.1M978.5M989.5M1.0B
2020950.7M870.3M874.5M862.5M
2019875.9M901.4M932.7M955.1M
2018811.9M827.6M839.7M859.6M
2017768.9M772.6M777.9M796.4M
2016722.4M734.8M750.4M763.5M
2015736.1M728.9M723.2M719.2M
2014757.6M752.8M748.5M740.1M
2013759.8M763.1M760.5M762.7M
2012735.9M742.4M751.5M767.1M
2011720.8M723.0M723.6M725.1M
2010699.5M704.2M709.0M713.7M
2009000694.7M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of CONMED Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 31, 2024
schwarzentraub barbara j
acquired
-
-
302
-
May 31, 2024
workman john l
acquired
-
-
302
-
May 31, 2024
council laverne h
acquired
-
-
302
-
May 31, 2024
aronson martha goldberg
acquired
-
-
302
-
May 31, 2024
concannon brian
acquired
-
-
302
-
May 31, 2024
bronson david m
acquired
-
-
302
-
May 31, 2024
farkas charles
acquired
-
-
302
-
May 31, 2024
lande jerome j.
acquired
-
-
302
-
May 13, 2024
bronson david m
bought
97,321
72.09
1,350
-

1–10 of 50

Which funds bought or sold CNMD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
added
48.00
-446
5,030
-%
Jun 06, 2024
WESTWOOD HOLDINGS GROUP INC
added
47.53
4,909,000
67,186,000
0.53%
May 30, 2024
EULAV Asset Management
reduced
-34.36
-1,292,680
1,193,190
0.03%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-291,000
792,000
0.01%
May 22, 2024
BURNEY CO/
reduced
-8.48
-201,605
407,928
0.02%
May 20, 2024
Virtu Financial LLC
sold off
-100
-668,000
-
-%
May 16, 2024
COMERICA BANK
sold off
-100
-56,207
-
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-5.19
-1,089,300
2,462,220
-%
May 16, 2024
JANE STREET GROUP, LLC
new
-
181,963
181,963
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-26.91
-2,341,920
2,688,530
-%

1–10 of 35

Are Funds Buying or Selling CNMD?

Are funds buying CNMD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CNMD
No. of Funds

Unveiling CONMED Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.12%
3,420,011
SC 13G/A
Feb 12, 2024
earnest partners llc
7.6%
2,345,697
SC 13G/A
Feb 09, 2024
capital research global investors
9.0%
2,757,108
SC 13G/A
Jan 22, 2024
blackrock inc.
16.4%
5,031,016
SC 13G/A
Feb 13, 2023
capital research global investors
7.2%
2,192,394
SC 13G
Feb 13, 2023
champlain investment partners, llc
4.19%
1,275,910
SC 13G/A
Feb 13, 2023
earnest partners llc
7.9%
2,402,352
SC 13G/A
Feb 09, 2023
vanguard group inc
11.23%
3,423,498
SC 13G/A
Jan 26, 2023
blackrock inc.
16.2%
4,922,968
SC 13G/A
Jan 20, 2023
blackrock inc.
16.2%
4,922,968
SC 13G/A

Recent SEC filings of CONMED Corp

View All Filings
Date Filed Form Type Document
Jun 14, 2024
144
Notice of Insider Sale Intent
Jun 05, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 03, 2024
3
Insider Trading

Peers (Alternatives to CONMED Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
180.4B
40.3B
-0.87% -1.28%
32.05
4.47
-2.84% -3.00%
67.6B
19.7B
-1.49% -8.74%
50.68
3.43
4.82% -17.56%
19.3B
3.9B
-8.68% -23.17%
41.69
4.92
5.72% 46.72%
17.2B
14.9B
-4.71% -24.07%
6.49
1.16
2.98% 207.68%
MID-CAP
9.6B
3.5B
-1.72% 24.73%
30.66
2.71
6.16% 35.06%
8.4B
12.4B
-11.97% -13.19%
21.71
0.68
-0.93% -18.83%
8.1B
2.6B
-6.15% -25.48%
-24.99
3.09
-6.25% -68.58%
5.4B
3.9B
-7.61% -31.99%
-56.77
1.38
0.23% 90.80%
3.4B
387.1M
-0.71% 28.31%
-215.21
8.86
30.82% 65.57%
2.0B
6.6B
-12.43% -18.98%
10.47
0.31
2.78% -0.87%
SMALL-CAP
1.5B
3.2B
15.14% 13.53%
-2.17
0.46
7.94% -1695.32%
390.3M
169.3M
0.92% -1.83%
-5.08
2.31
7.49% -244.90%
246.7M
324.0M
-3.14% -43.23%
-1.28
0.76
-3.19% -337.41%
50.2M
50.5M
2.84% -79.14%
-2.2
1
14.25% -10.06%
1.8M
3.7M
75.00% -80.56%
-0.15
0.49
5.77% 8.23%

CONMED Corp News

Latest updates
MSN11 Jun 202410:23 pm
Seeking Alpha25 Apr 202407:00 am
Simply Wall St18 Apr 202407:00 am

CONMED Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-4.5%312327305318295251275277242274249255233253238158214265234238218
Gross Profit-5.6%17218216817115513215215213615614214112813613472.00119142130131121
Operating Expenses3.8%13713213814314313312712711411911611610811110493.00106114109113110
  S&GA Expenses4.6%12311812513013012111511610310710510498.0099.0094.0084.0096.0010298.0010199.00
  R&D Expenses-3.1%14.0014.0012.0014.0013.0012.0013.0011.0011.0011.0011.0011.0010.0012.0010.009.0010.0012.0011.0012.0011.00
EBITDA Margin14.8%0.13*0.11*0.07*0.07*-0.03*-0.02*0.01*0.01*0.12*0.12*0.11*0.12*---------
Interest Expenses0.9%10.0010.0010.0010.0010.009.009.006.005.008.008.009.0010.0011.0012.0011.0010.0010.0011.0012.009.00
Income Taxes-25.0%6.008.004.004.001.00-37.12-30.4475.002.005.002.003.00-0.13-10.6411.00-5.34-2.442.002.001.00-2.98
Earnings Before Taxes-37.5%25.0041.0020.0017.002.00-10.5416.00-93.4817.0030.0017.0016.0010.0013.0017.00-32.743.0017.009.006.00-1.96
EBT Margin26.7%0.08*0.06*0.03*0.02*-0.08*-0.07*-0.03*-0.03*0.08*0.07*0.06*0.06*---------
Net Income-40.4%20.0033.0016.0014.002.0027.0046.00-16815.0024.0015.0013.0010.0024.007.00-27.406.0015.007.006.001.00
Net Income Margin26.1%0.07*0.05*0.05*0.08*-0.09*-0.08*-0.08*-0.11*0.07*0.06*0.06*0.06*---------
Free Cashflow-47.4%27.0052.0041.0022.00-8.10-17.2719.0013.00-3.3631.0016.0031.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets0.4%2,3092,3002,3262,3232,3202,2982,2922,0721,7861,7661,7541,7621,7471,7521,7431,7241,7511,7751,7581,7591,761
  Current Assets3.3%636616626616610581574577488460443443424417404379393397399397391
    Cash Equivalents39.3%34.0024.0031.0028.0026.0029.0033.0053.0025.0021.0032.0046.0037.0027.0036.0035.0024.0026.0030.0023.0023.00
  Inventory1.2%322318326327335332305290254232229211206195183176175165174173171
  Net PPE-2.3%118121120117115116114112109109109108109111112113114119117117117
  Goodwill-0.1%806807815816815815814757618618618618618618617617616618616616615
Liabilities-0.8%1,4551,4661,5291,5431,5681,5521,5761,3999969819981,0171,0211,0431,0601,0491,0491,0651,0571,0621,068
  Current Liabilities-6.2%291311376353321297209201188197183198182190179151160188161156151
  Long Term Debt1.7%9909739429719959851,036982704672703708725735760790773755781796804
    LT Debt, Current-------------------13.0014.0014.00
    LT Debt, Non Current-------------------781796804
Shareholder's Equity2.5%855834796780752746716673790785756744726709683675702710701697693
  Retained Earnings3.0%466453426416408413392352526497478469461457439438471471462460460
  Additional Paid-In Capital2.6%458447440433420413407401366397395394389383381377375379379377375
Shares Outstanding-31.00-31.0031.0031.00-30.0030.0029.00-29.0029.0029.00--------
Float----3,100---2,200---2,900---1,500---2,421-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-48.4%29,12156,39546,12726,673-3,847-11,59825,89318,74232833,78521,36234,27922,34420,14535,1265,5393,72140,87636,60021,577-3,920
  Share Based Compensation5.4%6,2405,9236,1866,4225,7265,7285,7545,7554,4634,2974,3274,2893,3872,9813,5323,5553,0322,9603,0083,1082,703
Cashflow From Investing58.1%-2,035-4,855-5,394-5,529-4,254-6,318-91,258-148,266-3,687-3,188-5,575-2,994-3,109-3,149-60.00-3,752-6,677-8,859-4,869-4,984-368,950
Cashflow From Financing71.0%-17,014-58,766-37,229-19,7875,35011,51546,875159,1217,489-40,789-29,792-22,095-8,872-27,164-35,6658,0312,739-36,974-23,424-17,675378,954
  Dividend Payments0.1%6,1536,1496,1456,1106,0986,0956,0925,8995,8745,8385,8305,8135,7755,7195,7125,7045,6835,6735,6585,6435,626
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CNMD Income Statement

2024-03-31
Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]  
Net sales$ 312,273$ 295,468
Cost of sales140,308140,147
Gross profit171,965155,321
Selling and administrative expense123,358130,083
Research and development expense13,59412,539
  Operating expenses136,952142,622
Income from operations35,01312,699
Interest expense9,59410,255
Income before income taxes25,4192,444
Provision for income taxes5,710625
Net income19,7091,819
Comprehensive income$ 20,078$ 4,695
Per share data:  
Basic (in dollars per share)$ 0.64$ 0.06
Diluted (in dollars per share)$ 0.63$ 0.06
Weighted average common shares:  
Basic (in shares)30,78030,511
Diluted (in shares)31,27231,204

CNMD Balance Sheet

2024-03-31
Consolidated Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 33,855$ 24,296
Accounts receivable, net241,461242,279
Inventories322,298318,324
Prepaid expenses and other current assets38,11030,750
Total current assets635,724615,649
Property, plant and equipment, net117,951120,722
Goodwill806,276806,844
Other intangible assets, net641,310649,484
Other assets107,994107,322
Total assets2,309,2552,300,021
Current liabilities:  
Current portion of long-term debt692708
Accounts payable101,63588,224
Accrued compensation and benefits49,93170,069
Other current liabilities139,146151,728
Total current liabilities291,404310,729
Long-term debt990,110973,140
Deferred income taxes64,00260,902
Other long-term liabilities109,075121,028
Total liabilities1,454,5911,465,799
Commitments and contingencies
Shareholders' equity:  
Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding00
Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2024 and 2023, respectively313313
Paid-in capital458,024446,535
Retained earnings466,082452,531
Accumulated other comprehensive loss(49,801)(50,170)
Less: 508,028 and 534,000 shares of common stock in treasury, at cost, in 2024 and 2023, respectively(19,954)(14,987)
Total shareholders’ equity854,664834,222
Total liabilities and shareholders’ equity$ 2,309,255$ 2,300,021
CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
 CEO
 WEBSITEconmed.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES4100

CONMED Corp Frequently Asked Questions


What is the ticker symbol for CONMED Corp? What does CNMD stand for in stocks?

CNMD is the stock ticker symbol of CONMED Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CONMED Corp (CNMD)?

As of Fri Jun 14 2024, market cap of CONMED Corp is 2.19 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CNMD stock?

You can check CNMD's fair value in chart for subscribers.

What is the fair value of CNMD stock?

You can check CNMD's fair value in chart for subscribers. The fair value of CONMED Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CONMED Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CNMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CONMED Corp a good stock to buy?

The fair value guage provides a quick view whether CNMD is over valued or under valued. Whether CONMED Corp is cheap or expensive depends on the assumptions which impact CONMED Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNMD.

What is CONMED Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jun 14 2024, CNMD's PE ratio (Price to Earnings) is 26.6 and Price to Sales (PS) ratio is 1.74. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CNMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CONMED Corp's stock?

In the past 10 years, CONMED Corp has provided 0.06 (multiply by 100 for percentage) rate of return.